"Diabetologická a endokrinologická ambulance - o své pacienty pečuje celkem devět lékařů - diabetologů, endokrinologů, obezitolog, šest zdravotních sester a jedna nutriční specialistka."

During the past decade, Milan Kvapil s.r.o., Diabetologicka ambulance conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Milan Kvapil s.r.o., Diabetologicka ambulance" are "Type 2 Diabetes" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Milan Kvapil s.r.o., Diabetologicka ambulance" in a lesser frequency.

Most popular intervention types in "Milan Kvapil s.r.o., Diabetologicka ambulance" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (2 trials), "Antihyperglycemic medication" (1 trials), "Dulaglutide" (1 trials), "Evolocumab" (1 trials) and "Insulin Degludec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Milan Kvapil s.r.o., Diabetologicka ambulance" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Milan Kvapil s.r.o., Diabetologicka ambulance". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Milan Kvapil s.r.o., Diabetologicka ambulance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Milan Kvapil s.r.o., Diabetologicka ambulance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".